Evidence map›Paper›PMID 40001354›Full record

ArticleAntibiotics (Basel, Switzerland)2025

A First Report on Multidrug-Resistant

Maja Anušić, Tatjana Marijan, Ana Mlinarić Džepina, Vladimira Tičić, Lucija Gršković, Jasmina Vraneš

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Synergistic Effects of Amikacin With Imipenem and Ciprofloxacin Against Multidrug-Resistance UropathogenicThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maja AnušićDepartment of Clinical Microbiology, Dr. Andrija Štampar Teaching Institute of Public Health, 10000 Zagreb, Croatia.
Tatjana MarijanDepartment of Clinical Microbiology, Dr. Andrija Štampar Teaching Institute of Public Health, 10000 Zagreb, Croatia.
Ana Mlinarić DžepinaDepartment of Clinical Microbiology, Dr. Andrija Štampar Teaching Institute of Public Health, 10000 Zagreb, Croatia.
Vladimira TičićDepartment of Clinical Microbiology, Dr. Andrija Štampar Teaching Institute of Public Health, 10000 Zagreb, Croatia.
Lucija GrškovićDepartment of Medical Microbiology and Parasitology, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
Jasmina VranešDepartment of Clinical Microbiology, Dr. Andrija Štampar Teaching Institute of Public Health, 10000 Zagreb, Croatia.ORCID 0000-0002-3282-0973

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesAntimicrobial resistance of the

methodsThe

resultsIn the first period, there were a total of 45 isolates of

conclusionsThere was no statistically significant difference in the frequency of detecting the

Indexed as

ESBL productionEscherichia coli O25 ST131fluoroquinolone resistancemolecular epidemiologymultidrug-resistant cloneurinary tract infections

Identifiers

PMID40001354
PMCPMC11852058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.